Albiglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist classified as an incretin mimetic, designed to improve glycemic control in adults with type 2 diabetes mellitus. It functions… Read more
Albiglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist classified as an incretin mimetic, designed to improve glycemic control in adults with type 2 diabetes mellitus. It functions by stimulating glucose-dependent insulin secretion and suppressing glucagon release to help manage blood glucose levels. To support the rigorous analytical requirements of peptide-based drug development, pharmaceutical laboratories utilize highly specific reference standards. This category provides essential impurities, metabolites, and stable isotope labelled compounds, which are critical for precise quality control and structural characterization. These materials are indispensable for performing reliable impurity profiling, validating complex analytical methods such as HPLC and mass spectrometry, and ensuring consistency throughout the drug manufacturing process. By serving as accurate benchmarks for identification and quantification, these reagents help maintain the high standards required for pharmaceutical analysis and regulatory compliance in the development of therapeutic peptides.